Submitted by Anonymous (not verified) on 12 August 2025 - 11:04
Human medicines European public assessment report (EPAR): Naveruclif, paclitaxel, Date of authorisation: 05/01/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Naveruclif, paclitaxel, Date of authorisation: 05/01/2024, Revision: 3, Status: Authorised